Alnylam Pharmaceuticals (ALNY) Q1 2019 Earnings

7FebConfirmed
Q2 2018
Q3 2018
Q4 2018
Q1 2019
-2.43
-2.09
-1.75
-1.41

Details

Expected EPS
-2.3
Actual EPS
-2.09
Surprise EPS
0.21
Surprise Percent
+9.13%

Description

Alnylam Pharmaceuticals (ALNY) has reported earnings of -2.09 per share for Q1 2019.

0 Comments

Share your thoughts